David Moore

Track

Insider profile

Currently holds positions in Guaranty Federal Bancshares Inc and Paul Mueller Co

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 46% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Guaranty Federal Bancshares Inc May 28, 2014 -
President, Chief Executive Officer, Secretary, Director Paul Mueller Co Sept. 5, 2011 -
David Moore's trades of Novo Nordisk A/S's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
DK Novo Nordisk A/S (NOVO-B)
Transaction date
Sale
Price
199.33
Quantity 95,252
Value DKK1,420,776
DK Novo Nordisk A/S (NOVO-B)
Transaction date
Sale
Price
34.67
Quantity 86,012
Value DKK2,692,271
DK Novo Nordisk A/S (NOVO-B)
Transaction date
Purchase
Price
71.44
Quantity 31,647
Value DKK488,894
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-05 2026-02-04
DK Novo Nordisk A/S (NOVO-B)
S Sale
95,252
199.33
DKK1,420,776 		95,252 199.33 DKK1,420,776
2025-11-11 2025-11-10
DK Novo Nordisk A/S (NOVO-B)
S Sale
86,012
34.67
DKK2,692,271 		86,012 34.67 DKK2,692,271
2025-11-11 2025-11-10
DK Novo Nordisk A/S (NOVO-B)
B Purchase
31,647
71.44
DKK488,894 		31,647 71.44 DKK488,894